Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Credit Suisse Upgrades Veoneer to Neutral, Raises Price Target to $37

Author: Benzinga Newsdesk | August 18, 2021 05:04am
Credit Suisse analyst Dan Levy upgrades Veoneer (NYSE:VNE) from Underperform to Neutral and raises the price target from $17 to $37.

Posted In: VNE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist